Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307281 · ClinicalTrials.gov registry record
Emphysema Research Registry and Biosample Repository
A clinical trial of Chronic Obstructive Pulmonary Disease and Emphysema, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00307281: Recruiting study of Chronic Obstructive Pulmonary Disease and Emphysema, sponsored by University of Pittsburgh.
NCT00307281 is a study of Chronic Obstructive Pulmonary Disease and Emphysema that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 3,000 participants, above the 1,719-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00307281, a study of Chronic Obstructive Pulmonary Disease and Emphysema, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this center, that attempts to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema. The Emphysema Research Registry will enable pulmonary research physicians to: 1) gather information and create a research registry of people who have been diagnosed with emphysema; 2) utilize this research registry with the purpose of conducting research that attempts to advance the understanding of emphysema and to evaluate new therapies; and, 3) use the research registry to identify potential candidates for future research programs. These aims will be achieved by the collection of DNA (genetic material)for analysis and storage in addition to pulmonary function tests and other medical information.
Primary Outcome
This research registry will allow us to to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh Emphysema/COPD Research Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2000-08 |
| Est. Completion | 2030-07 |
What NCT00307281 shows while recruiting
NCT00307281 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,719-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (75% higher).
The record links to 3 conditions, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00307281 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00307281 about?
NCT00307281 is a clinical study titled "Emphysema Research Registry and Biosample Repository". The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this cent...
What is the current status of trial NCT00307281?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2000-08. Estimated completion is 2030-07.
What conditions does trial NCT00307281 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease, Emphysema, Chronic Bronchitis.
Who is sponsoring clinical trial NCT00307281?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00307281 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00307281's enrollment target sits among peer trials
3,000 5th of 86 higher than 82 of 86 other Chronic Obstructive Pulmonary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
RECRUITING
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
RECRUITING · Phase 2
-
The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
RECRUITING · Phase 2
-
COPD Care Pathway Among Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia